SIRT3 and acute kidney injury: Sirt3 agonist HL could ameliorate cardiac hypertrophy by activating Sirt3 (Pillai et al., 2015) and improving fatty acid oxidation resulting in the inhibition of acute kidney injury induced by cisplatin (Li et al., 2020).